{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T01:46:55Z","timestamp":1766627215930,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbmt.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T11:30:27Z","timestamp":1570620627000},"page":"407-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life"],"prefix":"10.1016","volume":"26","author":[{"given":"George E.","family":"Georges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav","family":"Bar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Onstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean C.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazyar","family":"Shadman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona A.","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.10.002_bib0001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1200\/JCO.2011.38.4594","article-title":"Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation","volume":"30","author":"Khera","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bbmt.2007.06.003","article-title":"Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"13","author":"Majhail","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0003","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","article-title":"Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"116","author":"Sun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0004","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","article-title":"Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation","volume":"28","author":"Martin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0005","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/cncr.31114","article-title":"Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large B-cell lymphoma","volume":"124","author":"Myers","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0006","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bjh.13965","article-title":"A national study on conditional survival, excess mortality and second cancer after high-dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma","volume":"173","author":"Smeland","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0007","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2005-01-0035","article-title":"Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study","volume":"105","author":"Bhatia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0008","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.3324\/haematol.2014.119214","article-title":"Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway","volume":"100","author":"Smeland","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0009","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood-2018-02-831156","article-title":"Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report","volume":"131","author":"Holmqvist","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0010","unstructured":"D'Souza A, Fretham C. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR Summary Slides, 2018. Available at:https:\/\/www.cibmtr.org. Accessed 11\/10\/2019."},{"key":"10.1016\/j.bbmt.2019.10.002_bib0011","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/bjc.2016.180","article-title":"Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation","volume":"115","author":"Stenehjem","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0012","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/bmt.2016.338","article-title":"Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation","volume":"52","author":"Stenehjem","year":"2017","journal-title":"Bone Marrow Transplant"},{"year":"1994","series-title":"SF-36 physical and mental health summary scales: a user's manual","author":"Ware","key":"10.1016\/j.bbmt.2019.10.002_bib0013"},{"year":"1993","series-title":"SF-36 Health Survey: manual and interpretation guide","author":"Ware","key":"10.1016\/j.bbmt.2019.10.002_bib0014"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0015","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/cncr.31695","article-title":"Congestive heart failure in older adults diagnosed with follicular lymphoma: a population-based study","volume":"124","author":"Kenzik","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.blre.2018.06.002","article-title":"Venous thromboembolism incidence in hematologic malignancies","volume":"33","author":"Kekre","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0017","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.bbmt.2018.06.015","article-title":"Quality of life of caregivers of hematopoietic cell transplant recipients","volume":"24","author":"Jamani","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0018","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/cncr.27987","article-title":"Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"119","author":"Tichelli","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0019","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/0284186X.2017.1406137","article-title":"Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation","volume":"57","author":"Stenehjem","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0020","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2017-03-725671","article-title":"How I monitor long-term and late effects after blood or marrow transplantation","volume":"130","author":"Bhatia","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0021","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.2013.52.6582","article-title":"Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation","volume":"32","author":"Chow","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0022","first-page":"690","article-title":"Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes","author":"Bersvendsen","year":"201958","journal-title":"Acta Oncol"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0023","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1200\/JCO.2015.62.7562","article-title":"Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors","volume":"33","author":"Landier","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0024","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bmt.2012.5","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0025","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.203919","article-title":"Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors","author":"Majhail","year":"20191041084","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0026","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11764-018-0693-9","article-title":"An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation","volume":"12","author":"Syrjala","year":"2018","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0027","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bmt.2014.13","article-title":"Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study","volume":"49","author":"Bilmon","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0028","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbmt.2017.01.006","article-title":"Cardiovascular function in long-term hematopoietic cell transplantation survivors","volume":"23","author":"Armenian","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0029","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2009.09.015","article-title":"The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls","volume":"16","author":"Bishop","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.002_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bbmt.2016.12.620","article-title":"Herpes zoster in autologous hematopoietic cell transplant recipients in the era of acyclovir or valacyclovir prophylaxis and novel treatment and maintenance therapies","volume":"23","author":"Sahoo","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119306536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119306536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:10:41Z","timestamp":1761059441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119306536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1083879119306536"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.10.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy","name":"copyright","label":"Copyright"}]}}